Bacteria use a variety of methods to fight off the medications designed to destroy them. Ribosome-modifying enzymes are one of these weapons that are most common and these enzymes are becoming more widespread
According to a recent investigation, pathogenic bacteria exposed to the antibiotic albicidin rapidly improve their resistance by up to 1,000 times through a gene amplification process.
Ahmedabad (Gujarat) [India], August 2: Ahmedabad-based young pharma company offering innovative healthcare products, Uniza Healthcare has launched Aurelius, Gold and Collagen Serum Mask to strengthen its evolving dermatology range. South Korean brand, Aurelius is launched first time in In
There are just three primary kinds of antifungal drugs available today, and they all act by breaking the barrier that surrounds fungal cells. Despite the fact that they all assault the barrier, current therapies are quite specialised, which means that what kills one type of fungus may not ki
Mumbai (Maharashtra) [India], July 27: Wockhardt Ltd – global pharmaceutical and biotechnology is aiming to turnaround its business operations and has perused important strategic initiatives for the same. Company is eying big on the restructuring of the US Business, vaccine tie-up with Serum
New Delhi [India], July 5: BSI, the business improvement and standards company, today launched a new global Minimized Risk of Antimicrobial Resistance (AMR) certification designed to promote and attest to the responsible manufacturing of antibiotics in the global supply chain, helping to min
Gentamicin is a commonly used antibiotic in the treatment of severely unwell newborns. It is water soluble and is mostly excreted from the body through the urine. As a result, total body weight, which includes the weight of the body's water content, is utilised to calculate gentamicin dose.
A research team led by Professor Kelvin Yeung from the Department of Orthopaedics and Traumatology, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed) developed a new microneedle patch to provide a highly effective non-antibiotic approach for the treat
According to new research from Ghent, Belgium, intravenous treatment with MK-3402, a metallo-beta-lactamase inhibitor, can be a successful technique in combating antimicrobial resistance. The findings will be presented at ASM Microbe 2023, the American Society for Microbiology's annual meeti